News – Page 25 – Endpoints News

Prazer Therapeutics raises $20M; Carisma lets go of most staff

2 months ago

Firings sweep across FDA as former leaders lament the gutting of drug agency

2 months ago

Talkspace is using AI to make therapy podcasts for patients

2 months ago

Big ambitions at Merck and AstraZeneca — along with a few giant pitfalls — reshape top ranks of the R&D 15

2 months ago

RNA editing startup raises $155M to bring liver and lung disease therapy into clinic

2 months ago

Lilly claims Phase 2 win for siRNA approach to mixed dyslipidemia

2 months ago

Sanofi continues its bet on R&D by poaching GSK’s head of development

2 months ago

Updated: J&J’s third talc bankruptcy bid is stopped by Texas federal judge

2 months ago

Federal judge nixes FDA's lab-developed test rule, says it exceeded agency's authority

2 months ago

DC court sides with HHS in Vertex's fertility program fight

2 months ago

What’s next after Marks? At FDA, questions over more top exits and future vision for drug agency

2 months ago

Tenaya to lay off about one-third of staff, reveals heart gene therapy data

2 months ago

FDA sets new date for opioid-focused advisory meeting after earlier delay

2 months ago

Vaxcyte's Phase 2 pneumococcal vaccine data disappoint Wall Street

2 months ago

Corcept shares soar after Phase 3 win in platinum-resistant ovarian cancer

2 months ago

Merck’s PAH drug cuts risk of serious events by 76% in trial stopped for efficacy

2 months ago

AstraZeneca’s cholesterol pill is set for Phase 3, but lags behind Merck rival

2 months ago

Marks’ exit at FDA rattles an already teetering biotech industry

2 months ago

Lilly's heart disease drug could be dosed as little as once a year, study shows

2 months ago

LifeMine’s restructuring; Europe won’t renew authorization for PTC’s Duchenne drug

2 months ago

Inspirna, which was preparing for a Phase 3 cancer trial, has folded

2 months ago

Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025

2 months ago

Exclusive: Transcend notches Phase 2 win to treat PTSD, invigorating budding neuroplastogen class

2 months ago

BiomX’s phage therapy succeeds in Phase 2 diabetic bone infection study

2 months ago

First page Previous page 22 23 242526 27 28 Next page Last page